AU2020252417B2 - Salivary biomarkers for the detection of epidermoid cancer of the head and neck - Google Patents

Salivary biomarkers for the detection of epidermoid cancer of the head and neck

Info

Publication number
AU2020252417B2
AU2020252417B2 AU2020252417A AU2020252417A AU2020252417B2 AU 2020252417 B2 AU2020252417 B2 AU 2020252417B2 AU 2020252417 A AU2020252417 A AU 2020252417A AU 2020252417 A AU2020252417 A AU 2020252417A AU 2020252417 B2 AU2020252417 B2 AU 2020252417B2
Authority
AU
Australia
Prior art keywords
genus
salivary
bacteria belonging
subject
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020252417A
Other languages
English (en)
Other versions
AU2020252417A1 (en
Inventor
Vicente Manuel Navarro López
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionou Research SL
Original Assignee
Bionou Research S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionou Research S L filed Critical Bionou Research S L
Publication of AU2020252417A1 publication Critical patent/AU2020252417A1/en
Application granted granted Critical
Publication of AU2020252417B2 publication Critical patent/AU2020252417B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2020252417A 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck Active AU2020252417B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382253.3A EP3719498A1 (en) 2019-04-05 2019-04-05 Salivary biomarkers for the detection of head and neck epidermoid cancer (cecc)
EP19382253.3 2019-04-05
PCT/EP2020/059761 WO2020201575A1 (en) 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck

Publications (2)

Publication Number Publication Date
AU2020252417A1 AU2020252417A1 (en) 2021-12-02
AU2020252417B2 true AU2020252417B2 (en) 2025-12-18

Family

ID=67437232

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020252417A Active AU2020252417B2 (en) 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck

Country Status (10)

Country Link
US (1) US12584178B2 (enExample)
EP (2) EP3719498A1 (enExample)
JP (1) JP7557789B2 (enExample)
KR (1) KR20210149144A (enExample)
CN (1) CN114008458A (enExample)
AU (1) AU2020252417B2 (enExample)
CA (1) CA3135976A1 (enExample)
ES (1) ES3053185T3 (enExample)
PL (1) PL3948285T3 (enExample)
WO (1) WO2020201575A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12334375B2 (en) 2019-08-08 2025-06-17 Lam Research Corporation Spindle assembly for wafer transfer in a multi-station process module
KR20240052707A (ko) * 2022-10-14 2024-04-23 국립암센터 구강 미생물총 기반 구강암의 진단

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180003348A (ko) * 2016-06-30 2018-01-09 연세대학교 산학협력단 폐암의 진단 또는 폐암의 병기에 관한 정보를 제공하는 방법 및 이를 이용하는 키트
US20180010171A1 (en) * 2016-06-23 2018-01-11 The Charlotte Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System Compositions and methods for oral microbiome signatures

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180010171A1 (en) * 2016-06-23 2018-01-11 The Charlotte Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System Compositions and methods for oral microbiome signatures
KR20180003348A (ko) * 2016-06-30 2018-01-09 연세대학교 산학협력단 폐암의 진단 또는 폐암의 병기에 관한 정보를 제공하는 방법 및 이를 이용하는 키트

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EIMEAR HURLEY ET AL: "Comparison of the salivary and dentinal microbiome of children with severe-early childhood caries to the salivary microbiome of caries-free children", BMC ORAL HEALTH, vol. 19, no. 1, 14 January 2019, pages 1 - 14 *
HONGLI GONG ET AL: "Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1 December 2014 (2014-12-01), United States, pages 7356 - 7563 *
IAN GANLY ET AL.: "'Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, inde pendent of tobacco and alcohol and human papillomavirus'", Int J Canc, vol. 145(3), 22 January 2019 pages 775 - 784 *
JENN-REN HSIAO ET AL: "The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma", CARCINOGENESIS, 39(6), 13 April 2018, pages 778 - 787 *

Also Published As

Publication number Publication date
EP3948285C0 (en) 2025-09-03
US20220170111A1 (en) 2022-06-02
US12584178B2 (en) 2026-03-24
ES3053185T3 (en) 2026-01-20
EP3719498A1 (en) 2020-10-07
KR20210149144A (ko) 2021-12-08
EP3948285B1 (en) 2025-09-03
CN114008458A (zh) 2022-02-01
EP3948285A1 (en) 2022-02-09
WO2020201575A1 (en) 2020-10-08
JP7557789B2 (ja) 2024-09-30
AU2020252417A1 (en) 2021-12-02
PL3948285T3 (pl) 2025-12-01
CA3135976A1 (en) 2020-10-08
JP2022529909A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
KR102930361B1 (ko) 암의 평가 및/또는 치료를 위한 무 세포 dna
CN113066585A (zh) 一种基于免疫基因表达特征谱对ⅱ期结直肠癌患者预后进行高效快捷评估的方法
KR20230025895A (ko) 순환 종양 핵산 분자의 다중모드 분석
CN117305447A (zh) 宫颈癌dna甲基化标志物及其应用
AU2020252417B2 (en) Salivary biomarkers for the detection of epidermoid cancer of the head and neck
CA3152887A1 (en) Novel biomarkers and diagnostic profiles for prostate cancer integrating clinical variables and gene expression data
JP2020515264A (ja) 早期膵がんを診断するための方法およびキット
WO2011146937A1 (en) Methods and kits useful in diagnosing nsclc
JP2021506308A (ja) 遺伝子発現プロファイルを使用して肺癌を診断するための組成物および方法
CN114480636B (zh) 胆汁细菌作为肝门部胆管癌诊断及预后标志物的用途
CN118006815A (zh) 具核梭杆菌特异性dna序列及其应用和检测方法
JP2025535972A (ja) 肺癌診断用ｄｎａメチル化マーカー及びその用途
CN118159669A (zh) 一种用于诊断肝癌的核酸及蛋白检测试剂盒
KR102954588B1 (ko) 기관지폐포세척액의 마이크로바이옴을 포함하는 폐암 진단용 바이오마커 조성물
WO2022013880A1 (en) Blood based biomarkers for early diagnosis and follow up of breast cancer
WO2019095541A1 (zh) 一种诊断预示乳腺癌骨转移的组合物及诊断预示方法
CN101684489A (zh) 肺癌的一种诊断标志物
KR20240176856A (ko) 기관지폐포세척액의 마이크로바이옴을 포함하는 폐암 진단용 바이오마커 조성물
CN119685479A (zh) 用于胰腺癌早期诊断的sEV mRNA组合标志物、其应用及检测试剂盒
JP2023162781A (ja) 診断薬、薬効予測キット、薬効予測方法、及びマーカー
KR20240139498A (ko) 미생물 검출 제제를 포함하는 대장 질환 예측 또는 진단용 조성물
JP2025537955A (ja) 食道癌及び胃癌診断用ｄｎａメチル化マーカー及びその用途
CN118186078A (zh) 一种新型多靶点肺癌辅助诊断的标志物组合及其应用
CN119570928A (zh) 用于结直肠癌诊断和预后预测的lncRNA组合
CN115927644A (zh) 一种新型多靶点胃癌检测的标志物组合及其应用

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)